CVS Health Co. (NYSE:CVS) Shares Sold by Amalgamated Bank

Amalgamated Bank cut its position in CVS Health Co. (NYSE:CVS) by 4.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 310,170 shares of the pharmacy operator’s stock after selling 14,735 shares during the quarter. Amalgamated Bank’s holdings in CVS Health were worth $24,491,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the company. Atticus Wealth Management LLC raised its stake in CVS Health by 149.0% in the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 219 shares in the last quarter. Cornerstone Planning Group LLC lifted its stake in CVS Health by 111.5% during the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 243 shares during the last quarter. ZRC Wealth Management LLC increased its stake in CVS Health by 400.0% in the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after purchasing an additional 400 shares during the last quarter. Coston McIsaac & Partners lifted its position in shares of CVS Health by 42.6% during the 4th quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock worth $42,000 after buying an additional 161 shares during the last quarter. Finally, Tennessee Valley Asset Management Partners purchased a new position in shares of CVS Health in the 4th quarter valued at $50,000. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Up 1.4 %

Shares of NYSE CVS traded up $0.75 during midday trading on Friday, reaching $55.90. 23,942,078 shares of the company’s stock were exchanged, compared to its average volume of 11,752,378. The stock has a market capitalization of $70.45 billion, a PE ratio of 9.82, a price-to-earnings-growth ratio of 0.89 and a beta of 0.56. CVS Health Co. has a 52-week low of $53.70 and a 52-week high of $83.25. The business’s fifty day moving average price is $73.19 and its two-hundred day moving average price is $73.37. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.63 and a current ratio of 0.81.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The firm had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the business posted $2.20 earnings per share. Analysts forecast that CVS Health Co. will post 7 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Monday, April 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a yield of 4.76%. CVS Health’s dividend payout ratio (DPR) is 46.75%.

Insider Buying and Selling

In related news, Director Edward J. Ludwig bought 1,000 shares of the firm’s stock in a transaction on Thursday, May 2nd. The stock was bought at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the purchase, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Edward J. Ludwig bought 1,000 shares of the firm’s stock in a transaction on Thursday, May 2nd. The stock was bought at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the purchase, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The disclosure for this sale can be found here. Insiders own 0.24% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the subject of several research analyst reports. Royal Bank of Canada decreased their price objective on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research note on Thursday, February 8th. Leerink Partnrs downgraded CVS Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday. UBS Group cut CVS Health from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $85.00 to $60.00 in a report on Thursday. Barclays lowered their price target on CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a report on Thursday. Finally, Mizuho lowered their price target on CVS Health from $86.00 to $72.00 and set a “buy” rating on the stock in a report on Thursday. Eight investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $80.35.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.